Tru Niagen 150 mg
Food supplement declared in France, declaration No 2020-5-604
Tru Niagen 150 mg, from ChromaDex UK Limited, is a food supplement declared in France. Status: withdrawn from the market on 16 November 2024. Main ingredients: Nicotinamide (vitamin B3). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked. Its name nevertheless states a dose above the maximum set in France in 2006: see the composition.
- Brand
- not provided
- Food business operator placing the product on the market
- ChromaDex UK Limited
- Status
- Withdrawn from the market on 16 November 2024
- Form
- Capsule
- Daily dose
- 300 mg
- Directions for use
- 2 capsules per day
- Intended populations
- Men, Women
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Hair and nails, Concentration, Memory, Skin, Nervous system
Declaration 302520, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| nicotinamide riboside chloride | Nicotinamide (vitamin B3) | 900 mg | 54 mg |
The product name states 150 mg of nicotinamide (vitamine B3) per serving, above the maximum dose of 54 mg set by the Order of 9 May 2006, not revised since November 2006. Check the dose and number of servings on the label. The EFSA The tolerable upper intake level for adults, including food, is 900 mg per day.
Additives
E460, Hydroxypropyl Méthyl Cellulose, E470b
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Do not exceed the recommended daily dose. Food supplements cannot be used as a substitute for a varied and balanced diet and a healthy lifestyle. If you are pregnant, breastfeeding or taking medication, consult a healthcare practitioner prior to use. If you are pregnant, breastfeeding or taking medication, consult a healthcare practitioner prior to use. Keep out of the reach of young children. Do not exceed recommended dose. Food supplements must not be used as a substitute for a varied and balanced diet and a healthy lifestyle. If you are pregnancy, nursing, or taking other medications, please seek the advice of a healthcare professional prior to use. Not intended for use by children under 18. Keep out of reach of children.
Regulatory points
- Information
Withdrawn from the market on 16 November 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Tru Niagen 150 mg ChromaDex Europa B.V., declared in 2022 : different composition: 1 ingredient(s) added, 1 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Tru Niagen 150 mg: composition and regulation”, https://compoatlas.com/en/supplements/products/302520-tru-niagen-150-mg, updated 15 November 2026.